Do ABO Blood Group Antigens Hamper the Therapeutic Efficacy of Mesenchymal Stromal Cells?
Guido Moll(Karolinska Institutet), Katarina Le Blanc(Karolinska University Hospital), Yuji Teramura(University of Tsukuba), Annika K. Hult(Lund University), Martin L. Olsson(Lund University), Willem E. Fibbe(Leiden University Medical Center), Stella Larsson(Karolinska Institutet), Jessica J. Alm(Karolinska University Hospital), Bo Nilsson(Uppsala University), Lillemor Stenbeck-Funke(Uppsala University), Nina Heldring(Karolinska University Hospital), Helene Roelofs(Leiden University Medical Center), Osama A. Hamad(Uppsala University), Lena von Bahr(Karolinska University Hospital)
Cited by 75
Related Papers
Immunomodulatory properties of mesenchymal stromal cells
|Blood|2007|1.8k
A monoclonal antibody-defined antigen associated with gastrointestinal cancer is a ganglioside containing sialylated lacto-N-fucopentaose II.
|Journal of Biological Chemistry|1982|883
Immunobiology of Human Mesenchymal Stem Cells and Future Use in Hematopoietic Stem Cell Transplantation
|Biology of Blood and Marrow Transplantation|2005|481